WHO ICTRP trial
A three months study evaluating if the potassium binder sodium zirconium…
EUCTR2018-000175-33-SK · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2018-000175-33-SK |
|---|---|
| Public title | A three months study evaluating if the potassium binder sodium zirconium cyclosilicate can help manage a common side effect of heart failure treatment, and thereby allow heart failure treatment to be improved |
| Scientific title | A Phase II, Randomised, Double-Blind, Placebo Controlled, Parallel-Group, Multicentre, Three Month Duration Potassium Reduction Initiative to Optimize RAAS Inhibition Therapy with Sodium Zirconium Cyclosilicate in Heart Failure (PRIORITIZE HF) - PRIORITIZE HF |
| Primary sponsor | AstraZeneca AB |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Romania;United States;Hungary;Slovakia;Canada;Poland;Brazil;Russian Federation;Bulgaria |
| Conditions | Heart Failure; Hyperkalaemia MedDRA version: 20.0 Level: LLT Classification code 10008908 Term: Chronic heart failure System Organ Class: 100000004849 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Trade Name: Lokelma Product Name: Sodium zirconium cyclosilicate OS Product Code: AZD7270 Pharmaceutical Form: Powder for oral suspension INN or Proposed INN: Sodium zirconium cyclosilicate CAS Number: 242800-27-7 Concentration unit: g… |
| Registration date | Feb 8, 2019 |
| Target size | 280 |
| Secondary IDs | D9484C00001;NCT03532009;2018-000175-33-HU |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: